Milestone Pharmaceuticals (MIST) Stock Chart & Stock Price History $1.70 +0.01 (+0.29%) As of 03:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Milestone Pharmaceuticals Stock Price Performance The Milestone Pharmaceuticals (MIST) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 27.24%, with a year-to-date return of -27.75%. In the past month, the stock has increased 7.91%, reflecting recent market activity. As of the latest close, Milestone Pharmaceuticals traded at $1.70 with a market cap of $90.88 million and volume of 866,536 shares. Five years ago, the stock traded at $8.03, representing a 78.77% decrease over that period. At the time, it had a market cap of $211.24 million and a volume of 796,336 shares. Receive MIST Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Milestone Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.01%1 Month Performance+7.91%3 Month Performance+39.75%Year-To-Date Performance-27.75%1 Year Performance+27.24%5 Year Performance-78.77% MIST Stock Chart for Monday, August, 18, 2025 MIST Chart by TradingView Milestone Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$1.68$1.70+1.19%$1.72$1.66866,536 shs$90.88 million08/14/2025$1.74$1.68-3.45%$1.74$1.611.46 million shs$89.81 million08/13/2025$1.66$1.74+4.82%$1.74$1.641.38 million shs$93.02 million08/12/2025$1.55$1.66+7.10%$1.66$1.54990,935 shs$88.74 million08/11/2025$1.50$1.55+3.33%$1.59$1.50784,252 shs$82.86 million08/08/2025$1.51$1.50-0.66%$1.53$1.48460,202 shs$80.19 million08/07/2025$1.53$1.51-1.31%$1.55$1.49581,219 shs$80.73 million08/06/2025$1.54$1.53-0.65%$1.56$1.50589,977 shs$81.79 million08/05/2025$1.49$1.54+3.36%$1.55$1.46829,362 shs$82.33 million08/04/2025$1.43$1.49+4.20%$1.50$1.43581,181 shs$79.66 million Get the Latest News and Ratings for MIST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Milestone Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$1.45$1.43-1.38%$1.48$1.40671,601 shs$76.45 million07/31/2025$1.45$1.45$1.49$1.43442,402 shs$77.52 million07/30/2025$1.46$1.45-0.68%$1.53$1.421.22 million shs$77.52 million07/29/2025$1.55$1.46-5.81%$1.55$1.451.27 million shs$78.06 million07/28/2025$1.58$1.55-1.90%$1.59$1.52723,954 shs$82.86 million07/25/2025$1.57$1.58+0.64%$1.60$1.54490,799 shs$84.47 million07/24/2025$1.60$1.57-1.88%$1.64$1.55997,150 shs$83.93 million07/23/2025$1.54$1.60+3.90%$1.60$1.521.59 million shs$85.54 million07/22/2025$1.49$1.54+3.36%$1.59$1.491.69 million shs$82.33 million07/21/2025$1.58$1.49-5.70%$1.60$1.481.74 million shs$79.66 million07/18/2025$1.65$1.58-4.24%$1.67$1.561.74 million shs$84.47 million07/17/2025$1.67$1.65-1.20%$1.71$1.592.01 million shs$88.21 million Related Companies ABEO Stock Price Chart OLMA Stock Price Chart ALDX Stock Price Chart AMRN Stock Price Chart BNTC Stock Price Chart RCKT Stock Price Chart INBX Stock Price Chart NGNE Stock Price Chart CADL Stock Price Chart LRMR Stock Price Chart Receive MIST Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Milestone Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MIST) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access